First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - DRUG DISCOVERY CONSULTANTS LIMITED

ANALYSIS
Credit Risk Update: DRUG DISCOVERY CONSULTANTS LIMITED, DAVID E HANLEY & CO 128 BUXTON ROAD, HEAVILEY, STOCKPORT, CHESHIRE, SK2 6PL. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 January 2024. The company was incorporated on 12 February 2021.

The accounts next due date is 31 October 2025. There are no mortgages.

The above was based on public record information as at 31 December 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13199717
Date Incorporated: 12 February 2021
Date Latest Accounts: 31 January 2024
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 13199717
Annual Return: Unknown
Registered Office: DAVID E HANLEY & CO 128 BUXTON ROAD, HEAVILEY, STOCKPORT, CHESHIRE, SK2 6PL
SIC Code and Operations: 72110
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DRUG DISCOVERY CONSULTANTS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 10 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC494255 DRUG DISCOVERY DIRECTORY LTD Dissolved
09226743 DRUG DISCOVERY LIMITED Active
14211599 DRUG DISCOVERY SOLUTIONS LIMITED Active
12550587 DRUG DISCOVERY TECHNOLOGIES LTD Active - Proposal to Strike off
04206078 DRUG DOGS (UK) LIMITED Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd